Biosimilars/Follow-on-Biologics Market

Biosimilars/Follow-on-Biologics Market contains market size and forecasts of Biosimilars/Follow-on-Biologics in global, including the following market information:

• Global Biosimilars/Follow-on-Biologics Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Biosimilars/Follow-on-Biologics Market Sales, 2017-2022, 2023-2028, (K Pcs)
• Global top five Biosimilars/Follow-on-Biologics companies in 2021 (%)

The global Biosimilars/Follow-on-Biologics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Human Growth Hormone Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Biosimilars/Follow-on-Biologics include Novartis, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion, Biocon, Hospira, Merck Group and Biogen idec, Inc. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Wesurveyed the Biosimilars/Follow-on-Biologics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Biosimilars/Follow-on-Biologics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Biosimilars/Follow-on-Biologics Market Segment Percentages, by Type, 2021 (%)

• Human Growth Hormone
• Erythropoietin
• Monoclonal Antibodies
• Insulin
• Interferon
• Granulocyte-Colony Stimulating Factor
• Peptide
• Others

Global Biosimilars/Follow-on-Biologics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Biosimilars/Follow-on-Biologics Market Segment Percentages, by Application, 2021 (%)

• Blood Disorders
• Oncology Diseases
• Chronic and Autoimmune Diseases
• Growth Hormone Deficiencies
• Others

Global Biosimilars/Follow-on-Biologics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Biosimilars/Follow-on-Biologics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Biosimilars/Follow-on-Biologics revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Biosimilars/Follow-on-Biologics revenues share in global market, 2021 (%)
• Key companies Biosimilars/Follow-on-Biologics sales in global market, 2017-2022 (Estimated), (K Pcs)
• Key companies Biosimilars/Follow-on-Biologics sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• Synthon Pharmaceuticals
• Teva Pharmaceutical Industries
• LG Life Sciences
• Celltrion
• Biocon
• Hospira
• Merck Group
• Biogen idec, Inc.
• Genentech (Roche Group)